Taiwan Advance Bio-Pharmaceutical Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Advance Bio-Pharmaceutical Inc with three other companies in this sector in Taiwan: Handa Pharmaceuticals Inc (2018 sales of 93.69 million Taiwanese Dollars [US$3.07 million] of which 100% was New Medicine Development), Naturewise Biotech & Medicals Corporation (108.48 million Taiwanese Dollars [US$3.56 million] ), and Holy Stone Healthcare Co Ltd (172.84 million Taiwanese Dollars [US$5.67 million] ).

Sales Analysis. During the year ended December of 2018, sales at Taiwan Advance Bio-Pharmaceutical Inc were 168.35 million Taiwanese Dollars (US$5.52 million). This is an increase of 16.1% versus 2017, when the company's sales were 145.06 million Taiwanese Dollars. The sales level in 2018 was fairly close to the level five years ago: in 2013, Taiwan Advance Bio-Pharmaceutical Inc had sales of 163.49 million Taiwanese Dollars.